Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
198 hedge funds and large institutions have $2.31B invested in Exact Sciences in 2014 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 66 increasing their positions, 65 reducing their positions, and 21 closing their positions.
114% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 21
61% more capital invested
Capital invested by funds: $1.43B → $2.31B (+$876M)
13% more funds holding
Funds holding: 175 → 198 (+23)
11% more call options, than puts
Call options by funds: $102M | Put options by funds: $91.8M
2% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 65
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$71.7M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$49M |
| 3 |
William Blair & Company
Chicago,
Illinois
|
+$47.9M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$35.1M |
| 5 |
Jennison Associates
New York
|
+$26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$38.2M |
| 2 |
Goldman Sachs
New York
|
-$31.8M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$25.9M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$19.6M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$14.9M |
EXAS Hedge Fund Activity: Q4 2014 in Review
198 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2014, worth a combined $2.31B — up 61% from $1.43B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new EXAS positions and 21 closed out — a net gain of 24 holders — while 66 added to existing stakes and 65 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $71.7M. The largest seller was First Trust Advisors, cutting an estimated $38.2M.
- 198 institutional investors held Exact Sciences (EXAS) as of Q4 2014, up from 175 in Q3 2014.
- Funds reported $2.31B of Exact Sciences stock for Q4 2014, up 61% quarter-over-quarter.
- 45 funds opened new Exact Sciences positions in Q4 2014 and 21 closed out, a net change of +24 holders.
- The largest Exact Sciences buyer in Q4 2014 was Fidelity Investments, an estimated $71.7M added.
- The largest Exact Sciences seller in Q4 2014 was First Trust Advisors, an estimated $38.2M sold.
Based on aggregated 13F filings for Q4 2014.